Mengjun Ma
Impact in
- Genetics top 10%
- Mesenchymal stem cell research
-
- Cancer, Hypoxia, and Metabolism
Papers in
- Genetics 6
- Mesenchymal stem cell research 6
-
- Spondyloarthritis Studies and Treatments 4
- Co-authors
- Huiyong Shen (14 shared papers)Zhongyu Xie (12 shared papers)Jinteng Li (9 shared papers)Yanfeng Wu (8 shared papers)Shuizhong Cen (7 shared papers)Peng Wang (8 shared papers)Yanfeng Wu (9 shared papers)Zheng Guan (5 shared papers)
- Journals
- Cell Death and Disease (3 papers)Stem Cells (2 papers)iScience (2 papers)Stem Cell Research & Therapy (1 paper)Molecular Therapy — Nucleic Acids (1 paper)
- Partner nations
- China
In The Last Decade
Mengjun Ma
27 papers receiving 665 citations
Peers
Comparison fields: 5 of 62
- Genetics 108
- Cancer Research 64
- Molecular Biology 294
- Rheumatology 63
- Orthopedics and Sports Medicine 21
Countries citing papers authored by Mengjun Ma
This map shows the geographic impact of Mengjun Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengjun Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengjun Ma more than expected).
Fields of papers citing papers by Mengjun Ma
This network shows the impact of papers produced by Mengjun Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengjun Ma. The network helps show where Mengjun Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Mengjun Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 94 | |
| 2 | 2021 | 71 | |
| 3 | 2021 | 70 | |
| 4 | 2021 | 67 | |
| 5 | 2019 | 56 | |
| 6 | 2019 | 45 | |
| 7 | 2021 | 40 | |
| 8 | 2022 | 29 | |
| 9 | 2023 | 28 | |
| 10 | 2021 | 24 | |
| 11 | 2018 | 22 | |
| 12 | 2021 | 19 | |
| 13 | 2020 | 14 | |
| 14 | 2022 | 13 | |
| 15 | 2023 | 13 | |
| 16 | 2019 | 10 | |
| 17 | 2016 | 9 | |
| 18 | 2020 | 8 | |
| 19 | 2024 | 8 | |
| 20 | 2018 | 7 |
About Mengjun Ma
Mengjun Ma is a scholar working on Genetics, Rheumatology, Molecular Biology, Pathology and Forensic Medicine and Anesthesiology and Pain Medicine, having authored 28 papers that have together received 676 indexed citations. Recurring topics across this work include Mesenchymal stem cell research (6 papers), Sarcoma Diagnosis and Treatment (4 papers), Bone Metabolism and Diseases (4 papers), Spondyloarthritis Studies and Treatments (4 papers), Spinal Cord Injury Research (3 papers), Cervical and Thoracic Myelopathy (2 papers), TGF-β signaling in diseases (2 papers) and Receptor Mechanisms and Signaling (2 papers). The work is most often cited by research in Genetics (108 citations), Cancer Research (64 citations), Molecular Biology (294 citations), Rheumatology (63 citations) and Orthopedics and Sports Medicine (21 citations). Mengjun Ma has collaborated with scholars based in China. Frequent co-authors include Huiyong Shen, Zhongyu Xie, Jinteng Li, Yanfeng Wu, Shuizhong Cen, Peng Wang, Yanfeng Wu, Zheng Guan, Su’an Tang and Rujia Mi. Their work appears in journals such as Cell Death and Disease, Stem Cells, iScience, Stem Cell Research & Therapy and Molecular Therapy — Nucleic Acids.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.